RxElite, Inc.
RXEI · OTC
9/30/2008 | 6/30/2008 | 3/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Market Cap | $82 | $81 | $81 | $62 |
| - Cash | $1,348 | $2,655 | $1,081 | $10,114 |
| + Debt | $7,365 | $5,807 | $1,496 | $590 |
| Enterprise Value | $6,099 | $3,233 | $495 | -$9,461 |
| Revenue | $3,258 | $3,006 | $2,999 | $1,175 |
| % Growth | 8.4% | 0.2% | 155.2% | – |
| Gross Profit | $307 | $503 | $357 | -$169 |
| % Margin | 9.4% | 16.7% | 11.9% | -14.4% |
| EBITDA | $5,409 | -$2,512 | $2,267 | -$187 |
| % Margin | 166% | -83.6% | 75.6% | -15.9% |
| Net Income | -$10,966 | -$6,390 | -$7,040 | -$4,840 |
| % Margin | -336.6% | -212.6% | -234.7% | -411.8% |
| EPS Diluted | -0.094 | -0.055 | -0.061 | -0.055 |
| % Growth | -71.4% | 10.3% | -11.9% | – |
| Operating Cash Flow | -$1,074 | -$1,673 | -$2,007 | $862 |
| Capital Expenditures | $0 | $0 | $0 | -$1,157 |
| Free Cash Flow | -$1,074 | -$1,673 | -$2,007 | -$295 |